DIJETETSKI SUPLEMENTI U TRETMANU GOJAZNOSTI Od reklame do nauke Sergej Sergej M. Ostojić M. Ostojić Centar za zdravlje, vežbanje i sportske Centar za zdravlje, vežbanje i sportske nauke nauke Center for Health, Exercise and Sport Sciences Center for Health, Exercise and Sport Sciences Deligradska 27, Beograd Deligradska 27, Beograd www.chess.edu.rs www.chess.edu.rs Obesity Trends* Among U.S. Adults BRFSS, 1985 (*BMI ≥30) No Data <10% 10%–14% www.chess.edu.rs Obesity Trends* Among U.S. Adults BRFSS, 1986 (*BMI ≥30) No Data <10% 10%–14% www.chess.edu.rs Obesity Trends* Among U.S. Adults BRFSS, 1987 (*BMI ≥30) No Data <10% 10%–14% www.chess.edu.rs Obesity Trends* Among U.S. Adults BRFSS, 1988 (*BMI ≥30) No Data <10% 10%–14% www.chess.edu.rs
12
Embed
SKOK 2 Dijetetski suplementi u tretmanu · PDF fileDIJETETSKI SUPLEMENTI U TRETMANU GOJAZNOSTI Od reklame do nauke Sergej M. Ostoji ... zPOREKLO Vrsta...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
DIJETETSKI SUPLEMENTI
U TRETMANU GOJAZNOSTI
Od reklame do nauke
Sergej Sergej M. OstojićM. OstojićCentar za zdravlje, vežbanje i sportske Centar za zdravlje, vežbanje i sportske naukenauke
Center for Health, Exercise and Sport SciencesCenter for Health, Exercise and Sport Sciences
Deligradska 27, BeogradDeligradska 27, Beograd
www.chess.edu.rs www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1985(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1986(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1987(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1988(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
2
Obesity Trends* Among U.S. AdultsBRFSS, 1989(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1990(*BMI ≥30)
No Data <10% 10%–14%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1991(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1992(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1993(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1994(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
3
Obesity Trends* Among U.S. AdultsBRFSS, 1995(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1996(*BMI ≥30)
No Data <10% 10%–14% 15%–19%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1997(*BMI ≥30)
No Data <10% 10%–14% 15%–19% ≥20%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1998(*BMI ≥30)
No Data <10% 10%–14% 15%–19% ≥20%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 1999(*BMI ≥30)
No Data <10% 10%–14% 15%–19% ≥20%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2000(*BMI ≥30)
No Data <10% 10%–14% 15%–19% ≥20%
www.chess.edu.rs
4
Obesity Trends* Among U.S. AdultsBRFSS, 2001(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% ≥25%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2002(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% ≥25%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2003(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% ≥25%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2004(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% ≥25%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2005(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2006(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%
www.chess.edu.rs
5
Obesity Trends* Among U.S. AdultsBRFSS, 2007(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%
www.chess.edu.rs
Obesity Trends* Among U.S. AdultsBRFSS, 2008(*BMI ≥30)
No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%
www.chess.edu.rs
19991990
Obesity Trends* Among U.S. AdultsBRFSS, 1990, 1999, 2008
(*BMI ≥30)
2008
No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%
www.chess.edu.rs www.chess.edu.rs
Nutritivna i dijetetska manipulacija
DIJETETSKI SUPLEMENTIDIJETETSKI SUPLEMENTI
TRETMAN GOJAZNOSTITRETMAN GOJAZNOSTI
Farmakološka terapija
Fizička aktivnost
Bihejvioralne modifikacije i psihoterapija
Hirurške tehnike
www.chess.edu.rs www.chess.edu.rs
6
Korisni efekti redukcije telesne mase
Želja za čarobnom tabletom protiv gojaznosti
ZAŠTO DIJETETSKI SUPLEMENTI ?ZAŠTO DIJETETSKI SUPLEMENTI ?
Prihvatljiv oblik tretmana (za razliku od vežbanja ili red. ishrane)
Frustracija neuspešnim metodama i stigmatizam gojaznosti
Dostupnost suplemenata bez odlaska lekaru
Snažan pritisak proizvođača
Potreba za “prirodnim” sredstvom
Percepcija da je prirodno – bezbedno i sigurno
www.chess.edu.rs www.chess.edu.rs
Korisnici supp u SAD 60% (180 miliona)
Povremeni korisnici weight loss supp 50% (150 miliona)
EPIDEMIOLOGIJAEPIDEMIOLOGIJA
Povremeni korisnici weight loss supp. 50% (150 miliona)
Redovni korisnici weight loss supp. 15% (45 miliona)
Učestalost predgojaznosti (BMI > 25) 60% i raste
Does the Products Actually Works?Does the Products Actually Works?
www.chess.edu.rs www.chess.edu.rs
POREKLO Ekstrakt biljke Lagerstroemia speciosa
HEM MEHANIZAM Smanjenje apetita transport glukoze u ćeliju
Banaba Banaba (eng. banaba)(eng. banaba)
HEM. MEHANIZAM Smanjenje apetita, transport glukoze u ćeliju
KLINIČKA ISKUSTVA Dijabetičari ‐ sniženje konc. glukoze i redukcija TM (1‐3 kg mesečno)